Short communication · 2017
Short communicationPublished 2016
Treatment of Depression in Patients on Anticoagulation Therapy: Antidepressant-Rivaroxaban Drug Interactions
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The use of Oral Anticoagulants (OAC) is recommended for stroke prevention. Rivaroxaban is a new generation oral anticoagulant. Depression and anxiety are psychiatric disorders which frequently coexist with the Coronary Artery Disease (CAD) and other cardiovascular diseases. In the last decades, there has been an increase in the use of antidepressants. This literature review aims to provide a general view of pharmacokinetic knowledge of drug interactions between rivaroxaban and antidepressants. Since rivaroxaban is metabolized by CYP3A4, the use of antidepressants that are inhibitors of this isoenzyme, such as fluoxetine, sertraline, paroxetine and fluvoxamine must be avoided. Based on drug interactions in cytochrome p450, it has been concluded that the use of escitalopram, citalopram, venlafaxine, mirtazapine or milnacipran would be safer in these patients since these drugs have a minimum CYP 450 inhibition potential.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Remedies -Drugs interaction of some anticoagulant and antidepressant drugs
Research article · 31 Oct 2015
Stress study and estimation of a potent anticoagulant drug rivaroxaban by a validated HPLC method: Technology transfer to UPLC
Conference abstract · 17 Sep 2018
Compatibility studies of rivaroxaban, a novel oral anticoagulant drug, with excipients in film-coated tablets
Article · 2 Oct 2024
Pharmacokinetic Equivalence Study of the Oral Direct Inhibitor of Factor Xa Anticoagulant, Rivaroxaban Film-Coated Tablets, in Healthy Subjects Under Fasting and Fed Conditions
More from this journal
The newest in Journal of Drug Metabolism & Toxicology.
Short communication · 30 Dec 2025
Liver Drug Metabolism Mechanisms Challenges and Future Perspectives
Opinion · 30 Dec 2025
Hepatic metabolism forms the foundation of drug disposition in the human body
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Carlos Clayton Tôrres Aguiar”

